{"database": "lobbying", "table": "lobbying_activities", "rows": [[3486262, "a490ce4c-11d9-4f6a-98ef-98c31d958820", "Q4", "S-3 GROUP", 400774330, "VIATRIS (MYLAN, INC)", 2025, "fourth_quarter", "CPT", "Issues related to patent policy and reform, including to address patent thickets and FDA/PTO Coordination; S.527 Prescription Pricing for the People Act; S.1096 Preserve Access to Affordable Generics and Biosimilars Act; S.1041 Affordable Prescriptions for Patients Act", "HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2026-01-15T13:31:09-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3486262"], "units": {}, "query_ms": 0.3319599782116711, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}